Judith Baumeister

Title: Judith Baumeister: Innovator in FcRn/HSA Binding Molecules

Introduction

Judith Baumeister is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential therapeutic applications.

Latest Patents

Judith Baumeister holds a patent for "FcRn/HSA binding molecules and methods of use." This patent describes binding molecules that comprise a human neonatal Fc receptor (FcRn) binding molecule and at least one antigen-binding domain linked to the FcRn binding molecule. The patent also includes polynucleotides, vectors, host cells, and methods of production. Furthermore, it outlines methods for treating antibody-mediated disorders using an FcRn/antigen-binding molecule.

Career Highlights

Judith Baumeister is associated with Argenx BV, a company known for its innovative approaches in the field of immunology. Her work has been instrumental in advancing the understanding and application of FcRn binding molecules in therapeutic contexts.

Collaborations

Judith has collaborated with notable colleagues, including Vladimir Bobkov and Karen Silence, who have contributed to her research endeavors.

Conclusion

Judith Baumeister's work in the development of FcRn/HSA binding molecules represents a significant advancement in biotechnology, with the potential to impact the treatment of various antibody-mediated disorders. Her contributions continue to shape the future of therapeutic innovations.